Rallybio Corp
RLYB
Market Cap$46.05M
Close$
$0.60
105.1% upside
Current Fair Value
105.1% upsideUndervalued by 105.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $46.05 Million |
|---|---|
| Enterprise Value | $33.15 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.84 |
| Beta | -1.7 |
| Outstanding Shares | 44,128,059 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.66 |
|---|---|
| PEG | 1.76 |
| Price to Sales | - |
| Price to Book Ratio | 0.29 |
| Enterprise Value to Revenue | 40.13 |
| Enterprise Value to EBIT | -0.47 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Rallybio Corp
2,021 employees